Uncover key drivers, emerging technologies, and competitive movements shaping the isosorbide mononitrate tablet market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Isosorbide Mononitrate Tablet Market from 2026 to 2030?
The isosorbide mononitrate tablet market size has experienced robust growth in recent years. This market is projected to expand from $1.2 billion in 2025 to $1.26 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.3%. The historical growth can be attributed to factors such as the rising prevalence of coronary artery disease, the long-term use of nitrates in angina management, an increasing aging population, the availability of cost-effective generic drugs, and the expansion of hospital and retail pharmacy infrastructure.
A significant expansion is anticipated for the isosorbide mononitrate tablet market, which is forecast to attain a size of $1.55 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. Key drivers for this expansion over the projected period include the proliferation of chronic cardiovascular ailments, heightened demand for extended-release tablet formulations, increasing acceptance of online pharmacies, enhanced detection of angina and heart failure, and wider availability of heart medications in developing markets. Prominent developments during the forecast timeframe are expected to involve the adoption of long-acting cardiovascular maintenance treatments, an increasing favorability towards extended-release formulations, the expanding deployment of generic nitrate drugs, improved patient adherence facilitated by once-daily regimens, and the wider accessibility provided by online and retail pharmacies.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24268&type=smp
What Drivers Are Affecting Demand In The Isosorbide Mononitrate Tablet Market?
The increasing occurrence of cardiovascular diseases is projected to boost the expansion of the isosorbide mononitrate tablet market. These conditions, known as CVDs, encompass various heart and blood vessel disorders such as coronary artery disease, heart failure, and hypertension. The growing incidence of cardiovascular diseases mainly stems from poor dietary habits, frequently characterized by excessive saturated fats, trans fats, sodium, and added sugars, resulting in issues like obesity, high blood pressure, and elevated cholesterol. Isosorbide mononitrate tablets aid in treating these diseases by relaxing and dilating blood vessels, which in turn enhances blood circulation and lessens the heart’s effort, consequently easing chest pain (angina), decreasing blood pressure, and improving oxygen supply to the heart muscle. For example, the Global Burden of Disease study, cited by the American College of Cardiology, a US-based nonprofit medical association and professional society for cardiologists, in September 2025, reported 19.2 million cardiovascular disease deaths globally in 2023. Consequently, the increasing prevalence of cardiovascular diseases is fueling the expansion of the isosorbide mononitrate tablet market.
Which Segment Groups Are Influencing The Isosorbide Mononitrate Tablet Market?
The isosorbide mononitrate tablet market covered in this report is segmented –
1) By Dosage Form: Immediate-Release Tablets, Extended-Release Tablets
2) By Indication Type: Angina Pectoris, Coronary Artery Disease (CAD)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Immediate-Release Tablets: Low-Dose, Single Strength Tablets
2) By Extended-Release Tablets: Moderate-Dose, High-Dose, Once-Daily Formulation, Twice-Daily Formulation
What Trends Are Driving The Growth Trajectory Of The Isosorbide Mononitrate Tablet Market?
Leading companies within the isosorbide mononitrate tablet market are concentrating on developing novel products, such as extended-release (ER) formulations. This strategic focus aims to enhance patient compliance, provide sustained therapeutic effects, and optimize treatment outcomes for conditions like angina pectoris. An extended-release formulation functions as an advanced drug delivery system, facilitating the gradual release of medication over an extended period, thereby reducing dosing frequency and maintaining consistent blood levels. For instance, in February 2024, Zydus Lifesciences Limited, an India-based pharmaceutical manufacturing company, secured approval from the United States Food and Drug Administration (USFDA) to manufacture and market isosorbide mononitrate extended-release tablets USP in strengths of 30 mg, 60 mg, and 120 mg. These tablets are utilized to prevent chest pain (angina) in patients with coronary artery disease and are equivalent to the reference listed drug (RLD), imdur extended-release tablets.
Who Are The Top-Performing Companies In The Isosorbide Mononitrate Tablet Market In Recent Years?
Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co., Inc., AstraZeneca plc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Sandoz International GmbH, Qilu Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/isosorbide-mononitrate-tablet-global-market-report
How Does The Isosorbide Mononitrate Tablet Market Perform Across Major Global Regions?
North America was the largest region in the isosorbide mononitrate tablet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isosorbide mononitrate tablet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Isosorbide Mononitrate Tablet Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24268&type=smp
Browse Through More Reports Similar to the Global Isosorbide Mononitrate Tablet Market 2026, By The Business Research Company
Isoprene Market Report 2026
https://www.thebusinessresearchcompany.com/report/isoprene-global-market-report
Effervescent Tablet Market Report 2026
https://www.thebusinessresearchcompany.com/report/effervescent-tablet-global-market-report
Tablets Market Report 2026
https://www.thebusinessresearchcompany.com/report/tablets-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model